BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO Journal Specifications
Overview | |
Publisher | MEDICAL UNIV WARSAW |
Language | Polish |
Frequency | Irregular |
General Details |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO
Exploring Digital Health Horizons: A Narrative Review of E-Health Innovations in Poland, Spain, Romania and Estonia.
- 20 Mar 2024
- Prospects in Pharmaceutical Sciences
A financial perspective on the pharmaceutical industry
- 7 Mar 2024
- Prospects in Pharmaceutical Sciences
SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases
- 22 Feb 2024
- Prospects in Pharmaceutical Sciences
The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health
- 13 Feb 2024
- Prospects in Pharmaceutical Sciences
Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles
- 4 Feb 2024
- Prospects in Pharmaceutical Sciences
Antioxidant, antimicrobial and anticholinesterase activity of Dittrichia graveolens
- 27 Dec 2023
- Prospects in Pharmaceutical Sciences
Exploring Digital Health Horizons: A Narrative Review of E-Health Innovations in Poland, Spain, Romania and Estonia.
- 20 Mar 2024
- Prospects in Pharmaceutical Sciences
A financial perspective on the pharmaceutical industry
- 7 Mar 2024
- Prospects in Pharmaceutical Sciences
SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases
- 22 Feb 2024
- Prospects in Pharmaceutical Sciences
The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health
- 13 Feb 2024
- Prospects in Pharmaceutical Sciences
Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles
- 4 Feb 2024
- Prospects in Pharmaceutical Sciences
Antioxidant, antimicrobial and anticholinesterase activity of Dittrichia graveolens
- 27 Dec 2023
- Prospects in Pharmaceutical Sciences
FAQs on BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO
How long has BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO been actively publishing?
BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO has been in operation since 2008 till date.
What is the publishing frequency of BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO?
BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO published with a Irregular frequency.
How many articles did BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO publish last year?
In 2023, BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO publsihed 28 articles.
What is the eISSN & pISSN for BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO?
For BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, eISSN is 2080-1602 and pISSN is 2080-1602.
Who is the publisher of BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO?
MEDICAL UNIV WARSAW is the publisher of BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO.